Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
Clinical trial NCT02441803 · COMPLETED
Trial details
- NCT number
- NCT02441803
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-14
- Primary completion
- 2020-09-22
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.